Amira sales and marketing update

Amira will restructure and reduce headcount by about 25 (50%) to 25 in order to focus on early- to mid-stage clinical research. The cuts will come from discovery research and administrative support. CSO and co-founder Peppi Prasit will leave once a new EVP of R&D is identified. Jilly Evans, co-founder and VP of biology, and John Hutchinson, co-founder and VP of chemistry, will also be departing. ...